Insulin, an endogenously produced circulating peptide that enters the brain, has been shown to reduce ischemic brain and spinal cord damage in several animal models. Because of its potential clinical use in humans, the present study was undertaken to test the hypotheses that (a) survival and regional ischemic brain necrosis are improved by insulin; (b) insulin requires concomitant hy poglycemia to exert its neuroprotective effect; (c) insulin is still neuroprotective with delayed administration after an episode of postischemic hypotension; and (d) insulin is beneficial after normoglycemic, as well as hyperglycemic ischemia. Rats were subjected to 10.5 min two-vessel oc clusion forebrain ischemia followed by 30 min of hypo ten sion to increase the infarction rate. Insulin administered concomitantly with glucose significantly reduced the sei zure rate, as well as cortical and striatal neuronal necrosis
Insulin has a beneficial effect on clinical restitu tion (LeMay et ai., 1988a; Voll et ai., 1989; Strong et ai., 1990) , metabolic abnormalities (Siemkowicz et ai., 1982) , and structural damage following exper imental cerebral ischemia in the rat (V oil and Auer, 1988; Voll et ai., 1989) . In spite of the demonstra tion of a beneficial action of insulin in several lab oratories, the mechanism of insulin action in cere bral ischemia is unknown. It is even unclear whether insulin generally acts by causing systemic hypoglycemia, or by a direct central effect on the brain.
The fact that insulin is effective not only if given below that seen in untreated animals. Neuroprotection was seen whether insulin was given before or after a 30min episode of postischemic hypotension. Insulin re duced pan-necrosis in addition to selective neuronal ne crosis: The infarction rate was reduced in the cerebral cortex, thalamus, and substantia nigra pars reticulata.
Normoglycemic ischemia produced only selective neuro nal necrosis, but a beneficial effect on structural damage was also seen. The results indicate that insulin acts di rectly on the brain, independent of hypoglycemia, to re duce ischemic brain necrosis. Possible direct eNS mech anisms of action include an effect on central insulin re ceptors mediating inhibitory neuromodulation, an effect on central neurotransmitters, or a growth factor effect of insulin. Key Words: Brain-Ischemia-Insulin-Glu cose-Rat.
before ischemia (LeMay et ai., 1988a; Strong et ai., 1990) , but also after ischemia (Voll and Auer, 1988; Voll et ai., 1989) , weighs against an effect that could be caused by reducing preischemic blood glucose levels and thereby mitigating intracerebral intra ischemic acidosis. A mechanism not operating solely via systemic glycemia is thus suggested.
In the present study, we therefore examined whether insulin could benefit cerebral ischemia in dependent of systemic hypoglycemia. During the first 3 days of recovery after ischemia, we pre vented systemic hypoglycemia during ongoing insu lin administration through repeated glucose admin istration. The insulin regimens were begun after ce rebral ischemia had occurred; to (a) be consistent with the previous protocols employed in this labo ratory, (b) aid in dissecting the mechanism of insu lin action by obviating any possible confounding ef fect on preischemic glucose stores, and (c) mimic the realm of clinical situations where insulin could be of benefit in treating cerebral ischemia.
It was also deemed necessary to determine whether insulin is of benefit after normoglycemic ischemia, because in this and in our previous stud ies moderate glucose preloading was used to in crease the rate of brain infarction following tran sient brain ischemia (Myers and Yamaguchi, 1977) . Hence, we additionally studied the effect of post ischemic insulin following normoglycemic isch emia.
MATERIALS AND METHODS
A total of 47 male Wistar rats (Charles River Breeding Center, St. Constant, Quebec) weighing 250-450 g were used.
Ischemia model
Anesthesia was induced in rats that had been allowed free access to rat chow and water before and after sur gery. The animals were intubated under 3% halothane in a mixture of 40% O2 and 60% N20. After reducing the halothane to 1 %, the rats were ventilated on a Starling type ventilator. The ventral tail artery was cannulated and connected to a Statham transducer (Gould P50, Cleveland, Ohio, U.S.A.). Mean arterial blood pressure (MABP) was automatically recorded by computer every 6 s, and the bipolar interhemispheric EEG was monitored, and intermittently recorded. Core temperature was main tained at 37°C using a thermistor-regulated servo controlled heating blanket (Harvard, Edenbridge, Kent, England). Head temperature was monitored separately using a thermometer located in the external auditory me atus, and was regulated to 37 ± O.I°C using an overhead heating lamp located symmetrically over the skull vertex. A flexible silicon catheter, having both distal and lateral openings, was positioned via the right jugular vein, with the distal opening located in the inferior vena cava. Blood glucose levels were monitored using glucose oxidase re agent strips and a reflectance glucometer (Ames Co, Mishawaka, Indiana, U.S.A.).
The common carotid arteries were isolated. Following surgery, the rats were paralyzed with 0.6 mg i. v. suxa methonium chloride (Sigma, St. Louis, Missouri, U.S.A.). Blood gases, pH, and blood glucose were mea sured after a stabilization period of 20 min, immediately before induction of ischemia.
Cerebral ischemia was induced by bilateral carotid ar tery clamping in combination with controlled exsanguina tion (Smith et aI., 1984) . Trimethaphan (5 mg/kg i.v., Ar fonad, Roche, Etobicoke, Ontario, Canada) was given, blood was rapidly withdrawn via the central venous line into a prewarmed heparinized 10-ml syringe until the MABP reached 50 mm Hg, and both carotid arteries were clamped. Onset of an isoelectric EEG pattern consis tently occurred within 15-20 s following clamping and was used to time the duration of the ischemic period. Blood pressure was regulated to 50 mm Hg by withdrawal or reinfusion of blood through the central venous cathe ter. The carotid clamps were removed 10.5 min after the onset of an isoelectric EEG pattern, and the shed blood was rapidly reinfused. Blood glucose and arterial blood gas measurements were repeated 5 min after carotid clamp removal.
Although neuronal necrosis confined to a portion of CAl would be sufficient to generate a behavioral deficit (Auer et aI., 1989) , we wished to generate more severe and widespread lesions to be able to assess neuroprotec tion in important extrahippocampal areas as well. To that end, postischemic hypotension was used. Pilot experi ments without glucose loading revealed that 10.5 min of normoglycemic ischemia produced damage largely re stricted to the CAl sector of the hippocampus, cortical neuronal necrosis never exceeding 100 necrotic neurons per section. Infarcts were not seen, yet increasing the duration of the ischemic insult to 15 min (n = 2) or 12 min (n = 2) led respectively to no postischemic recovery, or to postischemic demise. Postischemic hypotension has been found to enlarge areas of infarction (Osborne et aI., 1987) . To produce a more severe neocortical lesion in volving infarction, and to mimic clinical postischemic hy potension, we induced 30 min of arterial hypotension fol lowing reperfusion. This resulted in more consistent and severe neocortical damage (see below) in spite of near physiologic preischemic glucose levels. Thus, 5-7 min af ter reperfusion, a second bolus injection of i. v. tri methaphan was given, and blood was withdrawn via the central venous line to clamp the MABP at 50 mm Hg for 30 min. The shed blood was then reinfused. This gave rise to a high rate of cortical infarction, though still allowing the quantity of preloaded glucose to be reduced to 1 g/kg, given by intraperitoneal (i.p.) injection, half that used in our previous studies (Voll and Auer, 1988; Voll et aI., 1989) . Clinically relevant preischemic glucose levels of 8.1-11.3 mM (Table 1) were thus attainable while still producing consistent infarction in untreated animals. Blood glucose, arterial blood gases, and pH measure ments were repeated after 10 min of postischemic stabi lization. Blood pressure was monitored for a further 15-20 min during recovery, blood glucose levels were re corded 2 h after ischemia and every 6 h thereafter, round the clock, for the first 3 days of recovery (Table 1) .
Experimental groups
Twenty-nine rats were randomly allocated to four groups (groups I-IV, Table 2 ) to examine whether insulin acts via induction of hypoglycemia, or by a direct CNS mechanism. The insulin used in the regimens described below consisted of porcine/bovine crystalline zinc insulin (CZI; Novo Laboratories Ltd, Willowdale, Ontario, Can ada) administered i. v. and longer acting zinc insulin sus pension (Lente, Novo Laboratories Ltd., Willowdale, Ontario, Canada) administered subcutaneously (s.c.).
Group I (n = 9) was left untreated and served as the control group. Group II was treated with insulin only, and was allowed to become hypoglycemic to allow compari son with groups III and IV in which hypoglycemia was prevented by glucose administration. Group II rats (n = 8) were given 7 IU/kg insulin (4.7 IU soluble insulin i.v., 2.3 IU Lente insulin s.c.) immediately following carotid clamp release. During the first 3 days of recovery, blood glucose concentrations in group II were kept between 1.5 and 4.5 mM by twice daily 1:2 CZI:Lente insulin. Sup plemental, rapid-acting insulin or i.p. glucose were given if required to maintain the blood glucose levels within the range of 1.5-4.5 mM.
Group III (n = 6) was given 7 IU/kg of insulin (1/3 soluble i.v., :;13 Lente s.c.) but also glucose 4 g/kg i.p., during reperfusion. To evaluate the effect of delayed in sulin administration, the same regimen of postischemic insulin and glucose was given in group IV (n = 6), but Values are means ± SO. 131 ± 7 124 ± 19 129 ± 12 128 ± 11 50.0 ± 0.4 52.0 ± 1.3 52.0 ± 1.2 52.0 ± 1.1 123 ± 18 125 ± 18 137 ± 19 130 ± 10 50.0 ± 1.2 50.0 ± 0.7 51.0 ± 1.0 52.0 ± 1.1 120 ± 26 118 ± 10 110 ± 16 130 ± 10 8.1 ± 3.3 10.9 ± 4.0 10.3 ± 3.2 11.3 ± 2.3 10.7 ± 3.0 12.8 ± 2.7 13.1 ± 3.0 10.4 ± 2.9 11.8 ± 1.0 6.6 ± 2.3 13.4 ± 4.5 13.0 ± 5.7 6.7 ± 2.6
3.0 ± 0.6b 5.3 ± 0.4 6. a Significantly lower than group I (p < 0.05).
b Significantly lower than group I (p < 0.001).
C Posthypotension for groups III and IV.
begun after the hypotensive period, ie, 35-37 min after carotid occlusion. During the first 3 days of recovery, 7 IU/kg insulin (again as a 1:2 ratio of CZI:Lente) was ad ministered s.c. every 12 h to groups III and IV. Venous blood glucose measurements were taken every 4-6 h and i.p. glucose was given as required to maintain blood glu cose levels within the normoglycemic range of 4.6-7.8 mM.
Because we had used glucose pre loading, although moderate, to increase the infarction rate, we also wished to determine whether insulin would have a beneficial ef fect after normoglycemic ischemia, without any glucose pre loading whatsoever. Hence, 14 additional rats were studied. After ischemia without glucose preloading, eight rats were treated with 7 IU/kg insulin s.c. immediately and six rats were left untreated.
Quantification of brain damage
Rats from all groups were killed after 1 week of recov ery by transcardiac perfusion fixation under 2% halo thane anaesthesia. The brains were processed and subse rially sectioned at 200-J.1m intervals to yield step sections encompassing the entire brain. Sections were stained with 2% acid fuchsin and 0. 1 % cresyl violet. Acidophilic neurons are known to be irreversibly damaged (necrotic) from previous studies (Auer et a!., 1985) .
Selective neuronal necrosis was scored as follows. In the cerebral cortex, where total cell counts per section were not available, the absolute number of acidophilic neurons in each hemisphere per section was counted and scored on a semi-logarithmic ranked scale as follows: 0--10 necrotic neurons = 0, 11-100 = 1, 10 1-1,000 = 2, > I ,000 = 3. In the striatum, two 250-J.1m dorsolateral microscopic fields were counted bilaterally at the coronal level of the septal nuclei at their widest point (Bregma -0.3-+0.2 mm; Paxinos and Watson, 1982) , and total neuronal counts in normal animals were established. In the hippocampus, the percent necrosis could be calcu lated from the known total neuronal counts available (Auer et a!., 1984) for each septotemporal level. Thus, in the CAl band of the hippocampus, throughout its entire septotemporal extent, the number of acidophilic neurons was counted and given as the percentage of the total neu ronal population. For both the caudate nucleus and hip pocampus, an integer score of 1 was assigned for <10% necrotic neurons, 2 for 11-50% necrotic neurons, and 3 for 51-100% necrotic neurons. In the lateral reticular nu cleus of the thalamus (LRN-ThaI), the entire crescent of the nucleus was evaluated for the percent neuronal death at its most prominent coronal level (Bregma -2.8 to -3.3 mm; Paxinos and Watson, 1982) , with a ranked scale assigned as for the caudate nucleus. Infarction, or parenchymal pan-necrosis, featuring glial necrosis, cavitation and/or dense macrophage infiltration of the neuropil as well as death of the neurons (Fig. 1 ) was scored separately. Infarction was noted in each brain re gion, in any of the coronal brain sections, in the left and right cerebral cortex, striatum, thalamus, pretectum, mid brain colliculi, and substantia nigra pars reticulata (SNPR). The percentage of animals showing infarction was compared among the four groups.
Rats dying before 72 h postischemia were included only in the calculation of mortality and seizure rate. They were excluded from analysis of histological data because mat uration of ischemic damage has been shown to occur for up to 72 h postischemia in the CAl sector of the hippo campus and neocortex (Kirino, 1982; Pulsinelli et aI., 1982) . Inclusion of rats dying before this period might
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. , thus have resulted in an apparent but spurious reduction in hippocampal and cortical damage by inclusion of rats surviving <3 days. In addition, rats dying before elective perfusion, in which immediate successful perfusion fixa tion was not achieved, or in which perfusion was deemed inadequate as judged by the microscopic presence of blood cells in the vasculature, were also excluded from the histological data analysis.
Statistical analysis of data
Physiological parameters, including blood glucose lev els, were assumed to be parametric variables and were compared using one-way analysis of variance, with Scheffe's test for multiple comparison between groups. Nonparametric statistical tests (Siegel and Castellan, 1988) , having roughly 90-95% of the power of their para metric counterparts, were used for the ranked histologic data and the infarction rates. Selective neuronal necrosis scores in each region were compared between groups us ing the Wilcoxon rank sum test. Intergroup mortality, seizure rates, and regional infarction rates were com pared using the Fisher's exact test with Bonferroni cor rection for multiple comparisons.
RESULTS

Physiologic parameters
The immediate postischemic glucose levels (Ta ble 1) were above the normal fasting range for all groups including group II, because the insulin had not yet had time to produce a hypoglycemic effect. However, blood glucose levels in group II began to fall after the period of postischemic hypotension, and subsequently during postoperative days 1-3, blood glucose levels in the insulin-treated group II were significantly lower than the untreated group I, and also lower than groups IIi and IV treated with postischemic insulin and glucose together (Table 1) . There were no significant differences in the remain ing physiologic parameters between groups, except for a lower preischemic pH in group IV.
Clinical data, survival
In the untreated control group I, seizures ap peared in 44% of animals and were always lethal, yielding identical mortality and seizure rates (Fig.  2) . Seizures were manifest as repetitive lateral rock ing movements and sound-sensitive running sei zures (Kesner, 1966) . Death occurred 12-74 h after ischemia. All surviving rats showed severe neuro logic impairment with spastic gait, poor forelimb motor function, and reduced feeding and grooming. Three rats showed marked weight loss due to poor feeding, severe postural deficits with spastic gait Clinical data. Compared with the untreated animals, survival was improved in the animals given both insulin and glucose (:p = 0.01 ). The difference in survival with insulin alone did not reach statistical significance. Seizures were significantly reduced to zero in both groups treated with con comitant insulin and glucose, whether the insulin was given prior to (early) or following (delayed) an episode of postisch emic hypotension (*p < 0.05 compared with untreated group receiving no insulin, Fisher's exact test). See text and Table  1 for details of treatment protocols in each group. and impaired balance, absent forelimb placing to tactile stimulation, and absent grooming behaviour. In group II, all but one glucose-preloaded insulin treated rat survived until elective perfusion; run ning seizures occurred in 37% of animals but remit ted without progressing to death (Fig. 2) .
All animals in groups III and IV, treated with both glucose and insulin, survived until elective perfusion. Seizures did not occur in either group and all rats appeared neurologically intact within 12 h of surgery.
Neocortical pathology
The untreated group I rats showed the most se vere damage of all groups, when considering either selective neuronal necrosis (Fig. 3) or infarction (Fig. 4) . Untreated animals showed selective neu ronal necrosis in the neocortex ranging from grade 1 to grade 3, whereas animals treated with insulin plus glucose showed scores of either 1 or 0 ( Fig. 3) . Seven of the 12 rats treated with insulin and glucose showed complete cortical protection. The reduction in selective neuronal necrosis seen with insulin alone (Fig. 3 ) did not achieve significance.
In addition to reducing selective neuronal necro sis, insulin plus glucose, whether given early or late, reduced cortical infarction rates (Fig. 4) , and cortical infarcts were in fact not seen in any animal treated with insulin plus glucose (Fig. 4) . The in farction rate was also reduced by insulin alone ( 4). Infarcts were present in four of the six untreated rats, being bilateral and multiple in three. These three untreated control rats corresponded to those with severe neurologic impairment (see above). The pan-necrotic damage consisted of ovoid or laminar infarcted regions (Fig. I) . In three hemispheres from these rats, these infarcts involved the entire depth of the cortex, exceeding 1,000 f..l m in greatest extent. In the cerebral cortex, thalamus, and substantia nigra pars reticulata (SNPR) a significantly re duced rate of infarction (pan-necrosis, see Fig. 1 ) is seen in all the insulin-treated groups, compared with untreated con trols receiving no insulin. The histologic lesions of pan necrosis in all these areas resembled Fig. 1 depicting the neocortex, and showed no apparent relationship to selective neuronal necrosis in that necrotic neurons were not conspic uously seen around the infarcts (*p < 0.05, :p < 0.01 , Fisher's exact test).
Striatal pathology
Striatal neuronal necrosis was most frequent and extensive in untreated group I rats (Fig. 3) . Four untreated animals showed neuronal necrosis, se vere (grade 3) in three. Insulin alone did not achieve a significant reduction in striatal neuronal necrosis, but no neuronal necrosis whatsoever was seen in groups III or IV, statistically significant when com pared with the untreated control group I (Fig. 3) .
The striatum showed only selective neuronal ne crosis, but never infarction.
Hippocampal pathology
Of all brain regions, the hippocampus showed the least protection. None of the differences in percent CAl neuronal necrosis (Fig. 3) achieved statistical significance, although only untreated animals showed CA3, CA4, and inconsistent dentate gran ule cell loss. Assessment of the differences by the number of hippocampi showing >50% cell loss at any one level also showed no significant differ ences. The results illustrate the hazard of reaching conclusions regarding reductions in brain necrosis based on examining solely the hippocampus. Pan necrosis was not seen in the hippocampus.
Thalamic pathology
Although five of the six surviving untreated group I rats had bilateral neuronal necrosis in the lateral reticular nucleus of the thalamus, damage in the LRN-Thal was not significantly reduced in any of the insulin-treated groups (Fig. 3) .
The rate of infarction in the dorsal thalamus was reduced by insulin ( Fig. 4) . In all insulin-treated groups, thalamic infarction was entirely absent ex cept for unilateral thalamic microinfarcts in one group III rat.
Brainstem pathology
Insulin also protected against damage in brain stem structures. The rate of infarction in the SNPR was reduced in all three insulin-treated groups (Fig.  4) . Three of the untreated rats had bilateral SNPR infarction, with coexistent bilateral tectal infarcts involving the superior colliculi and mesencephalic nuclei of the reticular formation. In groups III and IV, brains tern infarction was entirely absent except for unilateral SNPR and tectal micro infarcts seen in one group III rat. Thus, both groups III and IV had a significantly reduced rate of SNPR and tectal mes encephalic infarction compared with the untreated group I.
Insulin only versus insulin plus glucose
In all brain regions, when specific comparison was made between the groups treated with insulin plus glucose (III and IV) and the insulin-only group II, no statistically significant differences in damage scores emerged in any brain region.
Effect of insulin following non-glucose loaded ischemia
Postischemic insulin (7 Iu/kg) given to eight of 14 animals without glucose preloading (preischemic blood glucose levels 5.3 ± 1.4 mM) reduced the blood glucose values 2 h after ischemia from 4.2 ± 0.6 mM to 1.5 ± 0.83 mM (p < 0.005) and the mean blood glucose levels over postoperative days 1-3 from 5.5 ± 2.0 mM to 3. 1 ± 0.78 mM (p < 0.05; all values mean ± SD). Physiologic parameters (data not shown) were otherwise the same, apart from a higher P02 in the untreated rats (179 ± 11 versus 152 ± 6.8, mean ± SD, p < 0.005).
Clinically, all untreated animals survived, but two insulin-treated rats died of seizures. One died at 72 h and satisfactory perfusion-fixation was ob tained. Hence, this animal was included in the his tologic data analysis. Seizures occurred in another two insulin-treated animals, but remitted spontane ously.
In these animals, the cortical damage score was reduced by insulin from a mean of 2.0 to 0.8 (p < 0.05, Wilcoxon Rank sum test). Hippocampal dam age in CA 1 was 97% in untreated animals (higher than in all groups of the glucose preloaded series I-IV), and was significantly reduced to 66% (p < 0.01) in animals given insulin. In the LRN-Thal (p < 0.05) and SNPR (p < 0.01), but not the dorsal thal amus (p = 0.1), necrosis was less frequent in ani mals treated with insulin.
DISCUSSION
Findings from this study demonstrate that the neuroprotective action of P9stischemic insulin does not require profound hypoglycemia, because insulin exerted a neuroprotective action even when hypo glycemia was prevented by repeated systemic ad ministration of glucose. Selective neuronal loss in the cerebral cortex, striatum, and LRN-Thal, as well as infarction in the neocortex and midbrain were all significantly reduced. A significant protec tive effect was present even when insulin was ad ministered after a period of sustained hypotension, 35 min after carotid clamp release. Postischemic hy potension was used to simulate the more severe structural consequences of transient global isch emia, as seen in clinical cardiac arrest (Brierley et aI., 197 1; Cole and Cowie, 1987) , and probably aug ments brain damage via a mechanism involving postischemic loss of autoregulation (Symon et aI., 1976) . The induction of postischemic hypotension was also used because it is clinically relevant, being a common and important sequela of transient global brain ischemia. Experimentally, postischemic hy potension has been shown to adversely affect re covery (Cantu et aI., 1969) .
Insulin was also found to be beneficial after nor moglycemic ischemia. However here, as in our pre vious studies (Voll and Auer, 1988; Voll and Auer, 1991) , profound hypoglycemia, and hypoglycemia induced seizures, may be deemed hazardous both by increasing seizure-related mortality and by aug menting brain damage associated with increased levels of postischemic epileptic activity (Krumholz et aI., 1988; Voll and Auer, 1991) .
From a mechanistic point of view, the finding that systemic hypoglycemia is not a necessary compo nent of insulin's beneficial action suggests that the neuroprotective mechanism involves a direct insu lin action on CNS tissue. At least two mechanisms of action must be considered, inhibitory neuromod ulation and a growth factor effect. But a prerequi site for considering either mechanism is demon strated entry of peripherally injected insulin into the brain.
Physiological studies in animals and in humans reveal that insulin does indeed cross the blood brain barrier (Margolis and Altszuler, 1967; Wallum et aI., 1987) . The mechanism of CNS uptake of cir culating insulin across cerebral vessels involves en docytosis and intravesicular transport after insulin binding to receptors on brain endothelial cells (Duffy and Pardridge, 1987) . Thus, exogenously ad ministered insulin has ready access and is in fact specifically transported into the brain extracellular compartment.
Once in the brain, insulin might protect against ischemia-initiated excitatory damage by inhibitory neuromodulation. Insulin plays a neuromodulatory role in the CNS, causing neurophysiologic inhibi tion (Palovcik et aI., 1984) in most areas studied, except in specific regions such as the area postrema (Carpenter and Briggs, 1986) . Inhibition of neuronal firing has been demonstrated in vivo (Saller and Chiodo, 1980) and in vitro (Palovcik et aI., 1984) . The anatomic concentration of insulin receptors in synapse-rich dendritic fields (Hill et aI., 1986; Wer ther et aI., 1987) supports such a function of insulin in the modulation of synaptic transmission.
Many peptides with well known specific func tions outside the brain, including insulin (Hill et aI., 1986) , have been localized in brain tissue. In addi tion, insulin receptors are widely distributed throughout the brain (Havrankova and Roth, 1978; Pacold and Blackard, 1979; Zahniser et aI., 1984) on neurons, astrocytes (Albrecht et aI., 1982) , and ce-J Cereb Blood Flow Metab, Vol. 11, No. 6. 1991 rebral capillaries (Frank and Pardridge, 1981; Al brecht et ai., 1982) .
Insulin has been shown to alter brain glucose me tabolism quite independently of changes in blood glucose. Using a euglycemic clamp technique, Grunstein et ai. (1985) showed that insulin infusion significantly reduced glucose utilization in the hy pothalamus, locus ceruleus, and motor cortex. Thus, high-dose insulin administration following ischemia might inhibit glucose phosphorylation and thereby reduce lactic acidosis. However, decreased glucose utilization has only been demonstrated in select brain regions, Two studies that looked at the effect of insulin infusion under steady state condi tions for glucose showed no, or insignificant, reduc tions in mean regional glucose utilization, respec tively (Hertz et aI., 1981; Hom et aI., 1984) , Insulin receptors are inhomogeneously distrib uted throughout the CNS (Hill et aI., 1986; Pacold and Blackard, 1979; Werther et aI., 1987) . In the rat, olfactory (entorhinal cortex, olfactory bulb, pyri form cortex), hypothalamic, and limbic (septum, anterior preoptic area, amygdala, hippocampus) re gions have a high density of insulin receptors, prob ably involved in the various aspects of food-seeking behaviour. In the hippocampus, which functions in spatial memory, insulin receptors are localized to the dendrite-rich layers of the stratum oriens and stratum radiatum of CA 1 (Hill et aI., 1986; Werther et aI., 1987) . In addition, insulin receptors are quite densely distributed in brain regions subserving mo tor function, including the cerebellum, caudate putamen, and frontal cortex. Insulin receptors are also abundantly distributed in sensory cortical ar eas, but are present in relatively low densities in the LRN-Thal, SNPR, and the superior and inferior colliculi.
In addition to inhibiting excitatory processes in neurons by an effect on central neurotransmitter systems, insulin may act centrally to promote neu ronal survival via a neural growth factor-like effect. Central receptors for insulin-like growth factors ex ist (Araujo et aI., 1989; Hill et aI., 1988) . The neo natal brain secretes insulin-like growth factors (Shiu and Paterson, 1988) and ischemia itself may be ca pable of stimulating endogenous growth factor pro duction by the brain.
Other mechanisms of insulin action can be con sidered. Insulin infusion during steady-state glucose levels has been shown to reduce serum potassium levels (Grunstein et aI., 1985) by stimulating Na + / K + -ATPase. Changes in extracellular potassium al ter neuronal firing and brain metabolic rate. In creased extracellular potassium increases brain glu cose utilization (Gjedde et aI., 1980) . Thus, significant reductions in serum potassium, occur ring in association with high-dose insulin adminis tration, might beneficially reduce glucose utilization and brain metabolic rate during the early reperfu sion period. Insulin also directly stimulates brain Na + IK + -ATPase (Stahl, 1986) . By enhancing post ischemic extrusion of Na + , this could also reduce cellular sodium and water accumulation, thereby mitigating postischemic edema.
Insulin might also lessen ischemic neuronal ne crosis through an effect on central catecholamine metabolism. Insulin modulates catecholamine re lease and uptake. Infusion of insulin stimulates nor epinephrine release in the rat (McCaleb et aI., 1979) . Also insulin inhibits sodium dependent re uptake of norepinephrine (NE) by rat brain cells (Masters et aI., 1987) . The net effect is therefore an elevation of NE levels in the extracellular space. Catecholamines modulate ischemic brain damage. Bilateral lesions of the locus ceruleus projections to the forebrain enhance neuronal necrosis in the hip pocampal CA 1 region and neocortex following tran sient cerebral ischemia in rats (Blomqvist et aI., 1985) . Early postischemic administration of a mix ture of epinephrine and NE was found to reduce CA 1 neuronal necrosis in the rat (Koide et aI., 1986) . Thus, an insulin-induced elevation of brain catecholamines, through inhibition of catechol amine uptake and stimulation of release, might be a contributory mechanism whereby insulin reduces selective neuronal necrosis.
Lastly, insulin has been shown to inhibit glial up take of -y-aminobutyric acid (GABA; Bouhaddi et aI., 1988) . Incubation of cortical astroglial cultures with insulin induces a time-and dose-dependent in hibition of high-affinity GABA uptake. Enhanced GABA-mediated neuronal inhibition might reduce neuronal necrosis by reducing neuronal metabo lism. This suggestion is supported by a number of studies that have demonstrated a beneficial effect of GABAmimetic agents following ischemia (Kirino et aI., 1986; Sternau et aI., 1989; Voll and Auer, 1991) . Insulin action via inhibiting GAB A uptake might represent a mechanism whereby insulin could re duce both selective neuronal necrosis (by inhibiting excitation) and brain infarction (by inhibiting me tabolism and lactic acidosis).
Whatever insulin's mechanism of action, insulin protects against the consequences of ischemia in the brain (LeMay et aI., 1988a; Voll and Auer, 1988; Voll et aI., 1989; Fukuoka et aI., 1989; Strong et aI., 1990) and in the spinal cord (Robertson and Gross man, 1987; LeMay et aI., 1988b) , suggesting a gen eral beneficial effect in the CNS. These findings are of potential future significance to clinical medicine.
The fact that postischemic insulin reduces brain ne crosis after normoglycemic ischemia further ex pands the potential range of clinical applicability of this treatment to situations of normoglycemic, as well as hyperglycemic, ischemia. In addition, pro found hypoglycemia is not a necessary accompani ment of the beneficial action of insulin in ischemia, although the optimum range of glucose values re main to be defined. Recent results from the labora tory of one of the authors (R.N .A.) suggest that glucose values in the low-normal range may be op timal in reducing excitation-mediated damage. Nev ertheless, by preventing profound hypoglycemia during insulin administration, one of the major haz ards associated with insulin administration is obvi ated.
